[1] |
Pass RF, Arav-Boger R. Maternal and fetal cytomegalovirus infection: Diagnosis, management, and prevention[J]. F1000Res, 2018, 7:255.
doi: 10.12688/f1000research.12517.1
URL
|
[2] |
Lanzieri TM, Dollard SC, Bialek SR, et al. Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries[J]. Int J Infect Dis, 2014, 22:44-48.
doi: 10.1016/j.ijid.2013.12.010
pmid: 24631522
|
[3] |
Rawlinson WD, Boppana SB, Fowler KB, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: Consensus recommendations for prevention, diagnosis, and therapy[J]. Lancet Infect Dis, 2017, 17(6):e177-e188.
|
[4] |
邱锐琴, 吴小波, 杜志云, 等. 尿液病毒载量检测对先天性巨细胞病毒感染诊断及病情评估的价值分析[J]. 中国实验诊断学, 2021, 25(1):43-46.
|
[5] |
张顺先. 先天性巨细胞病毒感染状况及随访研究[D]. 中国疾病预防控制中心, 2013.
|
[6] |
刘玲玲, 黄媛, 马迪, 等. IL-17参与巨细胞病毒肝炎致病机制的研究[J]. 中国免疫学杂志, 2018, 34(1):31-35.
|
[7] |
北京地区母婴巨细胞病毒感染课题组. 围产期巨细胞病毒感染的前瞻性研究[J]. 中华围产医学杂志, 2010, 13(2):93-97.
|
[8] |
邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 5版. 北京: 人民卫生出版社, 2019:57-59.
|
[9] |
陈凯, 秦刚, 朱瑞良, 等. 中国新生儿先天性巨细胞病毒感染筛查策略的卫生经济学评价[J]. 中国卫生资源, 2021, 24(4):413-420.
|
[10] |
陈凯, 秦刚. 先天性巨细胞病毒感染筛查策略的研究进展[J]. 中国病毒病杂志, 2021, 11(1): 70-73.
|
[11] |
中国医师协会新生儿科医师分会,中国医师协会新生儿科医师分会感染专业委员会,中华新生儿科杂志编辑委员会. 新生儿巨细胞病毒感染管理专家共识[J]. 中华新生儿科杂志, 2021, 36(6):1-7.
|
[12] |
Yamamoto AY, Mussi-Pinhata MM, Marin LJ, et al. Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection?[J]. J Clin Virol, 2006, 36(3):228-230.
doi: 10.1016/j.jcv.2006.03.011
URL
|
[13] |
徐莉莉, 牟文凤, 杨丽, 等. 婴儿血液、尿液及母乳中病毒DNA检测在诊断人巨细胞病毒感染中的应用[J]. 中国当代儿科杂志, 2013, 15(9): 748-750.
|
[14] |
Imafuku H, Yamada H, Uchida A, et al. Clinical and ultrasound features associated with congenital cytomegalovirus infection as potential predictors for targeted newborn screening in high-risk pregnancies[J]. Sci Rep, 2020, 10(1):19706.
doi: 10.1038/s41598-020-76772-1
pmid: 33184458
|
[15] |
刘培辉, 田佳, 李伟艳, 等. 早产儿先天性巨细胞病毒感染特点及危险因素分析[J]. 新医学, 2021, 52(9):687-691.
|
[16] |
Yamaguchi A, Oh-Ishi T, Arai T, et al. Screening for seemingly healthy newborns with congenital cytomegalovirus infection by quantitative real-time polymerase chain reaction using newborn urine: An observational study[J]. BMJ Open, 2017, 7(1):e013810.
doi: 10.1136/bmjopen-2016-013810
URL
|
[17] |
Bokström H, Holst RM, Mattsson LA, et al. Congenital cytomegalovirus infection presenting with echogenic bowel and oligohydramnios[J]. Acta Obstet Gynecol Scand, 2007, 86(2):248-250.
doi: 10.1080/00016340600614020
URL
|
[18] |
Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection[J]. Rev Med Virol, 2007, 17(4):253-276.
pmid: 17579921
|
[19] |
Korndewal MJ, Mollema L, Tcherniaeva I, et al. Cytomegalovirus infection in the Netherlands: Seroprevalence, risk factors, and implications[J]. J Clin Virol, 2015, 63:53-58.
doi: 10.1016/j.jcv.2014.11.033
pmid: 25600606
|
[20] |
Basha J, Iwasenko JM, Robertson P, et al. Congenital cytomegalovirus infection is associated with high maternal socio-economic status and corresponding low maternal cytomegalovirus seropositivity[J]. J Paediatr Child Health, 2014, 50(5):368-372.
doi: 10.1111/jpc.12502
URL
|
[21] |
de Vries JJ, Korver AM, Verkerk PH, et al. Congenital cytomegalovirus infection in the Netherlands: Birth prevalence and risk factors[J]. J Med Virol, 2011, 83(10):1777-1782.
doi: 10.1002/jmv.22181
URL
|